SwebbtvKriget kan bli Mellanösterns svarta svan, oljepriset sänker Europa i Omvärldsanalys 274
PeerTube
Jag får lätt näsblod och tar inte aspirin. Inte heller bra för magen. Av Nattokinase har jag inte fått några blödningar. Har tagit mellan 300 och 600 mg per dygn (alltid samtidigt) i över ett halvår. Har sänkt blodtrycket efter kort tid. Nu tar jag 400 mg. Mina lipidvärden har jag inte testat efter att jag börjat med Natto.
Här den kinesiska studien som visar förbättrade lipidvärden efter ett års intag av Nattokinase. Dosen är 10 800 FU. Det motsvarar 540 mg. Doser på 3 600 FU per dygn (180mg) och lägre sägs vara ineffektiva.
"We found that NK at a dose of 10,800 FU/day effectively managed the progression of atherosclerosis and hyperlipidemia with a significant improvement in the lipid profile. A significant reduction in the thickness of the carotid artery intima-media and the size of the carotid plaque was observed. The improvement rates ranged from 66.5 to 95.4%. NK was found to be ineffective in lowering lipids and suppressing atherosclerosis progression at a dose of 3,600 FU/day. The lipid-lowering effect of NK was more prominent in subjects who smoked, drank alcohol, and subjects with higher BMI. Regular exercise further improved the effects of NK. Co-administration of vitamin K2 and aspirin with NK produced a synergetic effect. No noticeable adverse effects associated with the use of NK were recorded. In conclusion, our data demonstrate that atherosclerosis progression and hyperlipidemia can be effectively managed with NK at a dose of 10,800 FU/day."
https://pmc.ncbi.nlm.nih.gov/articles/PMC9441630/
Här den kinesiska studien som visar förbättrade lipidvärden efter ett års intag av Nattokinase. Dosen är 10 800 FU. Det motsvarar 540 mg. Doser på 3 600 FU per dygn (180mg) och lägre sägs vara ineffektiva.
"We found that NK at a dose of 10,800 FU/day effectively managed the progression of atherosclerosis and hyperlipidemia with a significant improvement in the lipid profile. A significant reduction in the thickness of the carotid artery intima-media and the size of the carotid plaque was observed. The improvement rates ranged from 66.5 to 95.4%. NK was found to be ineffective in lowering lipids and suppressing atherosclerosis progression at a dose of 3,600 FU/day. The lipid-lowering effect of NK was more prominent in subjects who smoked, drank alcohol, and subjects with higher BMI. Regular exercise further improved the effects of NK. Co-administration of vitamin K2 and aspirin with NK produced a synergetic effect. No noticeable adverse effects associated with the use of NK were recorded. In conclusion, our data demonstrate that atherosclerosis progression and hyperlipidemia can be effectively managed with NK at a dose of 10,800 FU/day."
https://pmc.ncbi.nlm.nih.gov/articles/PMC9441630/